Vitruvia Medical AG Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-	-	-	-	-1.54
Depreciation & Amortization	-	-	-	-	0.35
Change in Accounts Receivable	-	-	-	-	-0.81
Change in Accounts Payable	-	-	-	-	0.78
Change in Other Net Operating Assets	-	-	-	-	1.01
Operating Cash Flow	-	-	-	-	-0.21
Capital Expenditures	-	-	-	-	-2.91
Other Investing Activities	-	-	-	-	0.71
Investing Cash Flow	-	-	-	-	-2.2
Issuance of Common Stock	-	-	-	-	2.83
Financing Cash Flow	-	-	-	-	2.83
Foreign Exchange Rate Adjustments	-	-	-	-	0.02
Net Cash Flow	-	-	-	-	0.44
Free Cash Flow	-	-	-	-	-3.12
Free Cash Flow Margin	-	-	-	-	-54.11%
Free Cash Flow Per Share	-	-	-	-	-2.12
Change in Net Working Capital	1.77	1.77	-1.06	0.97	-

Source: S&P Capital IQ. Standard template. Financial Sources.